Effectiveness and safety of abatacept for the treatment of patients with primary Sjögren’s syndrome

Overview of attention for article published in Clinical Rheumatology, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 29 X posts from 28 X users, with an upper bound of 51,481 followers.

RT @ClinRheumatol: #Abatacept is safe and effective for the treatment of primary #Sjögren’s Syndrome and can improve salivary flow, xerosto…

RT @ClinRheumatol: #Abatacept is safe and effective for the treatment of primary #Sjögren’s Syndrome and can improve salivary flow, xerosto…

RT @carvicab: Una muestra de 11 pacientes con Abatacept que muestra mejoría de la xerostomia y los síntomas sistémicos de la enfermedad #Sj…

RT @ClinRheumatol: #Abatacept is safe and effective for the treatment of primary #Sjögren’s Syndrome and can improve salivary flow, xerosto…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 25 additional X posts.